...
首页> 外文期刊>World Journal of Gastroenterology >A pharmacodynamic model of portal hypertension in isolated perfused rat liver
【24h】

A pharmacodynamic model of portal hypertension in isolated perfused rat liver

机译:大鼠离体灌注肝中门脉高压的药效学模型

获取原文

摘要

AIM: To develop a pharmacodynamic model of portal hypertension from chronic hepatitis. METHODS: Pathological changes and collagen depositions were analyzed using morphometry to confirm CCl4-induced chronic hepatitis. At d0, d28, d56 and d84 of the process, the portal perfused velocities (μL/min) in isolated rat livers were exactly controlled with a quantified pump. The pressure (mmHg) was monitored with a Physiological System. The geometric concentrations of phenylephrine or acetylcholine were added to a fixed volume (300 mL) of the circulating perfusate. The equation, the median effective concentration and its 95% confidence intervals of phenylephrine or acetylcholine were regressed with Prism-4 software in non-linear fit and various slopes. In the isolated perfused rat livers with chronic hepatitis, both median effective concentrations were defined as the pharmacodynamic model of portal hypertension. RESULTS: At d0, d28, d56 and d84, the equations of portal pressure potency from the concentrations of phenylephrine used to constrict the portal vein in isolated perfused rat livers were Y = 0.1732 + 0.3970/[1 + 10(-4.3061-0.4407 X)], Y = -0.004934 + 0.12113/[1 + 10(-3.1247-0.3262 X)], Y = 0.0104 + 0.2643/[1 + 10(-8.8462-0.9579 X)], and Y = 0.01603 + 0.12107/[1 + 10(-5.1134-0.563 X)]; the median effective concentrations were 1.69 × 10-10 mol/L, 2.64 × 10-10 mol/L, 5.82 × 10-10 mol/L, and 8.24 × 10-10 mol/L, respectively. The equations from the concentrations of acetylcholine used to relax the portal vein were Y = -0.4548 + 0.3274/[1 + 10(6.1538 + 0.5554 X)], Y = -0.05391 + 0.06424/[1 + 10(3.8541 + 0.3469 X)], Y = -0.2733 + 0.22978/[1 + 10(3.0472 + 0.3008 X)], and Y = -0.0559 + 0.053178/[1 + 10(5.6336 + 0.5883 X)]; the median effective concentrations were 8.40 × 10-10 mol/L, 7.73 × 10-12 mol/L, 5.98 × 10-11 mol/L, and 2.66 × 10-10 mol/L, respectively. CONCLUSION: A pharmacodynamic model of portal hypertension in isolated perfused rat livers with chronic hepatitis was defined as the median effective concentrations of phenylephrine and acetylcholine.
机译:目的:建立慢性肝炎门脉高压的药效学模型。方法:应用形态计量学分析病理变化和胶原蛋白沉积,以确认CCl 4 诱发的慢性肝炎。在过程的d 0 ,d 28 ,d 56 和d 84 处,门脉灌注速度(μL / min),用定量泵精确控制离体大鼠肝脏。用生理系统监测压力(mmHg)。将去氧肾上腺素或乙酰胆碱的几何浓度添加到固定体积(300 mL)的循环灌注液中。用Prism-4软件以非线性拟合和各种斜率对苯肾上腺素或乙酰胆碱的方程式,中位数有效浓度及其95%置信区间进行回归。在患有慢性肝炎的隔离灌流大鼠肝脏中,两个有效浓度均定义为门脉高压的药效学模型。结果:在d 0 ,d 28 ,d 56 和d 84 时,门静脉压力潜能方程由在离体灌注大鼠肝脏中用于缩窄门静脉的去氧肾上腺素的浓度为Y = 0.1732 + 0.3970 / [1 + 10 (-4.3061-0.4407 X)],Y = -0.004934 + 0.12113 / [ 1 + 10 (-3.1247-0.3262 X)],Y = 0.0104 + 0.2643 / [1 + 10 (-8.8462-0.9579 X)],Y = 0.01603 + 0.12107 / [1 + 10 (-5.1134-0.563 X)]];中位数有效浓度为1.69×10 -10 mol / L,2.64×10 -10 mol / L,5.82×10 -10 mol / L / L和8.24×10 -10 mol / L。用于放松门静脉的乙酰胆碱浓度方程为Y = -0.4548 + 0.3274 / [1 + 10 (6.1538 + 0.5554 X)],Y = -0.05391 + 0.06424 / [1 + 10 (3.8541 + 0.3469 X)],Y = -0.2733 + 0.22978 / [1 + 10 (3.0472 + 0.3008 X)],Y = -0.0559 + 0.053178 / [1 + 10 (5.6336 + 0.5883 X)];中位数有效浓度为8.40×10 -10 mol / L,7.73×10 -12 mol / L,5.98×10 -11 mol / L / L和2.66×10 -10 mol / L。结论:门静脉高压症在慢性肝炎的离体灌流大鼠肝脏中的药效学模型定义为去氧肾上腺素和乙酰胆碱的中位有效浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号